Heart Disease News and Research

Latest Heart Disease News and Research

Merck discontinues MK-1903 niacin receptor agonist development program with Arena Pharmaceuticals

Arena Pharmaceuticals, Inc. announced today Merck and Co., Inc.'s decision (through an affiliate) to discontinue development of MK-1903, an investigational niacin receptor agonist to treat atherosclerosis being developed under its research collaboration with Arena. Merck also informed Arena that the company will not continue the collaboration.

24 Dec 2009

Lawmakers brace for conference as House Liberals vow not to give in on key issues

The Los Angeles Times reports that Democrats are looking ahead — and at each other — before beginning the "potentially difficult" process of reconciling the Senate and House versions of health care reform.

23 Dec 2009

Protective benefits of Alzheimer's and cancer may lead to new diagnostic treatments

People who have Alzheimer's disease may be less likely to develop cancer, and people who have cancer may be less likely to develop Alzheimer's disease, according to a new study published in the December 23, 2009, online issue of Neurology®, the medical journal of the American Academy of Neurology.

23 Dec 2009

Majority of Australians think H1N1 vaccination is not necessary

Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.

23 Dec 2009

Thyroid cancer on the rise

As seen on "NBC Nightly News" Monday, December 21, the thyroid cancer rate is rising rapidly, especially among women. The American Thyroid Association's members are working to educate more people about thyroid cancer as well as treat and cure it.

23 Dec 2009

Health overhaul will keep insurers from dropping people after they become too expensive

The Los Angeles Times reports on some of the provisions in the health care bills will affect individuals because they will regulate how insurers treat people with chronic diseases.

23 Dec 2009

An FDA 'ambiguity' means patients get unapproved devices

A Chicago surgeon invented a silicone and metal ring to repair heart valves, and implanted them in 150 patients before his new device received FDA approval, The Wall Street Journal reports.

23 Dec 2009

Volcano lauds revised guidelines for treating severe coronary artery disease patients

Volcano Corporation, a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, reacted positively to the new guidelines for treating coronary disease and heart attacks using percutaneous coronary intervention (PCI), a procedure that treats narrowed blood vessels.

23 Dec 2009

BioLife Solutions receives ISO 13485:2003 certification

BioLife Solutions, Inc., a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announced that it has successfully completed audits of its quality systems and GMP production facility in Bothell, Washington by BSI Group and has been issued a certification to ISO 13485:2003, an international standard for quality systems supporting the design, development, and manufacture of medical devices.

23 Dec 2009

ABBM grants certification for medical community who treats obesity and related conditions

The American Board of Bariatric Medicine (ABBM) recently administered its certification exam designed to recognize doctors, nurse practitioners and physicians assistants who practice bariatric medicine and the non-surgical medical management of overweight and obese patients.

23 Dec 2009

Tips to achieve fitness and weight loss goals

More than 100 million Americans made New Year resolutions for 2009, and four out of five were not able to stick with them, according to the third annual Franklin Covey New Year’s Resolution survey released in January 2009.

23 Dec 2009

CEO Cancer Gold Standard accreditation for Aldagen

Aldagen, Inc. has received CEO Cancer Gold Standard™ accreditation, recognizing the company’s commitment to taking concrete actions to reduce the cancer risk of its employees and their families through screenings, early detection, and healthy changes in lifestyle and in the workplace.

23 Dec 2009

Beta blockers may increase risk of anemia-induced adverse cardiovascular events

Routinely used to treat patients for heart attack or high blood pressure, beta blockers are known for their role in helping to protect the heart. A new study in the January issue of the journal Anesthesiology looks at the effects of beta blockers on surgical outcomes, revealing that the cardioprotective effects of the medication could be compromised by acute surgical anemia.

23 Dec 2009

Study reveals patient characteristics can affect image quality of MDCT scans

A large multicenter international trial found that the image quality of multi-detector computed tomography (MDCT) scans, used for the noninvasive detection of coronary artery disease, can be significantly affected by patient characteristics such as ethnicity, body mass index (BMI), and heart rate, according to a study in the January issue of the American Journal of Roentgenology.

23 Dec 2009

ARCA biopharma submits Gencaro trial protocol for review under the FDA’s SPA process

ARCA biopharma, Inc. today announced that it has submitted a study protocol for review under the U.S. Food and Drug Administration’s (FDA) Special Protocol Assessment (SPA) process for the design of a clinical trial to assess the safety and efficacy of GencaroTM, in approximately 3,000 patients with chronic heart failure who have the genotype that appears to respond most favorably to Gencaro. Gencaro is the Company’s investigational, pharmacologically unique beta-blocker and mild vasodilator.

23 Dec 2009

NHLBI grant for identifying genetic and epigenetic causes of human congenital heart disease

Researchers at Children's Hospital Boston and Brigham and Women's Hospital have received funding from the National Heart, Lung, and Blood Institute (NHLBI) to support their search for undiscovered gene defects that cause congenital heart disease. The $4.19 million, 6-year grant is part of the Pediatric Cardiac Genomics Consortium (PCGC), which seeks to identify genetic and epigenetic causes of human congenital heart disease, and relate genetic variants present in the congenital heart disease patient population to clinical outcomes.

23 Dec 2009

Benefits of dispatcher-assisted bystander CPR outweigh potential injury risks

Dispatchers should assertively give cardiopulmonary resuscitation (CPR) instructions to bystanders who suspect someone is in cardiac arrest because the benefits from correctly recommending CPR for someone who needs it greatly outweigh the risks from recommending CPR for someone who does not, researchers said in Circulation: Journal of the American Heart Association.

23 Dec 2009

Brazilian researchers perform autopsy study to examine the causes H1N1 death

Brazilian researchers have performed the first-ever autopsy study to examine the precise causes of death in victims of the H1N1 swine flu.

23 Dec 2009

Second successful phrenic nerve decompression surgery

The Plastic Surgery Center today announced that immediately following a rare phrenic nerve surgery to repair his paralyzed diaphragm, a 47-year-old man has reported significantly improved breathing and feels “15 years younger.” The surgery marked the second known case of successful phrenic nerve decompression, both of which were performed by a New Jersey medical team led by Dr. Matthew Kaufman of the Plastic Surgery Center in Shrewsbury, New Jersey.

23 Dec 2009

Elizabethtown DI exceeds standard performance markers set by the RBMA

Opening day for any business is generally a nerve-wracking experience. Last-minute surprises are not uncommon. For Shonna Galloway, administrator for the brand-new Elizabethtown Diagnostic Imaging, however, the day before her employer's grand opening in October 2007 was one she'll never forget.

23 Dec 2009

Heart Disease News and Research

Latest Heart Disease News and Research

Merck discontinues MK-1903 niacin receptor agonist development program with Arena Pharmaceuticals

Lawmakers brace for conference as House Liberals vow not to give in on key issues

Protective benefits of Alzheimer's and cancer may lead to new diagnostic treatments

Majority of Australians think H1N1 vaccination is not necessary

Thyroid cancer on the rise

Health overhaul will keep insurers from dropping people after they become too expensive

An FDA 'ambiguity' means patients get unapproved devices

Volcano lauds revised guidelines for treating severe coronary artery disease patients

BioLife Solutions receives ISO 13485:2003 certification

ABBM grants certification for medical community who treats obesity and related conditions

Tips to achieve fitness and weight loss goals

CEO Cancer Gold Standard accreditation for Aldagen

Beta blockers may increase risk of anemia-induced adverse cardiovascular events

Study reveals patient characteristics can affect image quality of MDCT scans

ARCA biopharma submits Gencaro trial protocol for review under the FDA’s SPA process

NHLBI grant for identifying genetic and epigenetic causes of human congenital heart disease

Benefits of dispatcher-assisted bystander CPR outweigh potential injury risks

Brazilian researchers perform autopsy study to examine the causes H1N1 death

Second successful phrenic nerve decompression surgery

Elizabethtown DI exceeds standard performance markers set by the RBMA

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Heart Disease News and Research

Latest Heart Disease News and Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in